People

Jeremy Levin

Co-Founder & Executive Chairman at Ovid Therapeutics

Co-founder and executive chairman of Ovid Therapeutics. Served as CEO before transitioning to executive chairman on January 1, 2026. Previously led Teva and strategic alliances at Novartis, and held executive leadership at Bristol Myers Squibb. Also chairs Gensaic’s board according to Ovid’s June 2026 quarterly filing. Distinct from Bessemer investor Jeremy Levine. He is also chairman of Gensaic’s board, as confirmed by Gensaic’s current directory and Ovid’s June 2026 filing.

Current affiliation

Ovid Therapeutics · Co-Founder & Executive Chairman

Investment range

— – —

Sweet spot

—

Investments on record

4

Investments

$53M2026-04-20	Ovid Therapeutics	Jeremy Levin
$80M2025-10-03	Ovid Therapeutics	Janus Henderson Investors, RA Capital Management, Eventide Asset Management, Cowen Healthcare Investments, Ally Bridge Group, Jeremy Levin
$32M2019-02-20	Ovid Therapeutics	BVF Partners L.P., Jeremy Levin
$35MUnknown date	Ovid Therapeutics	BVF Partners L.P., Jeremy Levin

SHOW MORE